The new crystal form of deltamethrin (right), created by heating and cooling the original form (left), is up to 12 times more effective against mosquitoes. Image credit: Jingxiang Yang
Researchers use a simple, inexpensive technique to develop a new fast-acting form of deltamethrin that may help with growing insecticide resistance
Through a simple process of heating and cooling, New York University researchers have created a new crystal form of deltamethrin—a common insecticide used to control malaria—resulting in an insecticide that is up to 12 times more effective against mosquitoes than the existing form.
The findings, published in the journal Proceedings of the National Academy of Sciences (PNAS), may provide a much-needed and affordable insecticide alternative in the face of growing resistance among mosquitoes.
“The use of more active crystal forms of insecticides is a simple and powerful strategy for improving commercially available compounds for malaria control, circumventing the need for developing new products in the ongoing fight against mosquito-borne diseases,” said Bart Kahr, professor of chemistry at NYU and one of the study’s senior authors.
“Improvements in malaria control are needed as urgently as ever during the global COVID-19 crisis,” added Kahr. “The number of deaths from malaria in Africa this year is projected to double as a result of coronavirus-related disruptions to supply chains. We need public health measures to curtail both infectious diseases, and for malaria, this includes more effective insecticides.”
Malaria is a major public health challenge worldwide, with more than 200 million cases and 400,000 deaths reported each year. Insecticides such as deltamethrin can prevent the spread of diseases carried by mosquitoes and are often sprayed indoors and on bed nets. However, mosquitoes are increasingly becoming resistant to insecticides, leaving researchers and public health officials searching for alternatives with new modes of action.
Many insecticides, including deltamethrin, are in the form of crystals—the research focus for Kahr and fellow NYU chemistry professor Michael Ward. When mosquitoes step on insecticide crystals, the insecticide is absorbed through their feet and, if effective, kills the mosquitoes.
As part of their research on crystal formation and growth, Kahr and Ward study and manipulate insecticide crystals, exploring their alternative forms. In their PNAS study, the researchers heated the commercially available form of deltamethrin to 110°C/230°F for a few minutes and let it cool to room temperature; this resulted in a new crystallized form of deltamethrin, composed of long, tiny fibers radiating from a single point.
When tested on Anopheles quadrimaculatus and Aedes aegypti mosquitoes—both of which transmit malaria—and fruit flies, the new crystal form of deltamethrin worked up to 12 times faster than the existing form. Fast-acting insecticides are important for quickly controlling mosquitoes before they reproduce or continue spreading diseases.
The new form also remained stable—and able to rapidly kill mosquitoes—for at least three months.
To simulate how the two forms of deltamethrin would perform in stemming the spread of malaria, the researchers turned to epidemiological modeling that suggests that using the new form in indoor spraying in place of the original form would significantly suppress malaria transmission, even in regions with high levels of insecticide resistance. Moreover, less of the new form would need to be used to achieve the same effect, potentially lowering the cost of mosquito control programs and reducing environmental exposure to the insecticide.
“Deltamethrin has been a leading tool in combating malaria, but it faces an uncertain future, threatened by developing insecticide resistance. The simple preparation of this new crystal form of deltamethrin, coupled with its stability and markedly greater efficacy, shows us that the new form can serve as a powerful and affordable tool for controlling malaria and other mosquito-borne diseases,” said Ward.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Research finds how an insect-eating plant harnesses rain energy to power its traps
Researchers at the University of Bristol have discovered how a carnivorous plant kills its prey using rain energy.
- Researchers reveal how an insect-eating plant uses rain energy to power its traps
The Slender Pitcher Plant, Nepenthes gracilis, is amongst the most ingenious: Its elaborate cup-shaped leaves are equipped with a canopy-like hanging lid that turns into a deadly springboard for ants ...
- The evolving arsenal against mosquito-borne diseases
Genetic engineering is breaking new ground in the control of mosquito-borne diseases. However, a genetic engineering approach isn’t the only option, as many biotech companies aim to prove.
- Have An Ant Problem? Try These 3 Insect-Repelling Plants
Attempting to rid your house of an ant problem can feel close to impossible sometimes. Did you know there are plants that will do the job for you?
- Company cooperation could deliver blow to nematodes
Protection against other types of nematodes may prove important outside of North America. BASF is in its fifth year testing the NRS trait. So far, soybeans with this trait yield 8% more on average ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Quantifying spatial heterogeneity of malaria in the endemic Papua region of Indonesia: Analysis of epidemiological surveillance data
This study suggests that areas with varying levels of transmission-intensities exhibited distinct characteristics. Malaria was distributed in a markedly disproportionate manner throughout the region, ...
- Lab-engineered antibody appears to protect from malaria, study shows
U.S. government researchers found that a lab-engineered antibody protected most participants from infection with the malaria parasite -- including all of those who received a higher dose of the ...
- Monoclonal antibody prevents malaria in US adults: Study
One injection of a candidate monoclonal antibody (mAb) known as L9LS was found to be safe and highly protective in U.S. adults exposed to the malaria parasite, according to new results. Additional ...
- Monoclonal Antibody Studied for Prevention of Malaria
A next-generation antimalarial monoclonal antibody, L9LS, administered intravenously or subcutaneously, shows protective efficacy against controlled malaria infection, without evident safety concerns, ...
- Monoclonal antibody shown to be effective against malaria for up to six months
A large team of researchers affiliated with a host of institutions across the U.S. has developed a monoclonal antibody proven to be effective against malaria, perhaps for as long as six months, in a ...